BioCentury | Oct 18, 2019
Company News
Management tracks: Sirtex makes interim CEO permanent; plus Magenta, Pyxis, Stoke, Cadent, StemoniX, Enzyvant, Syapse and Stalicla
...first CMO. He was executive director of Swedish Cancer Institute at Providence St. Joseph Health. Stalicla S.A....
...Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Syapse Inc. Cadent Therapeutics Inc. StemoniX Inc. Stalicla S.A....
...Block, Associate Editor Enzyvant Sciences GmbH Stoke Therapeutics Inc. Sirtex Medical Ltd. Magenta Therapeutics Inc. Syapse Inc. Cadent Therapeutics Inc. StemoniX Inc. Stalicla S.A....
